Department of Obstetrics and Gynaecology, Epsom and St Helier University Hospitals NHS Trust, Dorking Road, London, UK.
St George's University of London, London, UK.
Int Urogynecol J. 2022 Nov;33(11):2941-2949. doi: 10.1007/s00192-022-05123-7. Epub 2022 Mar 7.
The mesh controversy has highlighted the need for robust evidence of treatment safety and efficacy, particularly in the surgical treatment of stress urinary incontinence (SUI). Current trials demonstrate heterogeneity in outcomes reported as well as outcome measures used, restricting the ability to synthesize data and produce robust research evidence (Doumouchtsis et al. 5). Patient-reported outcomes (PROs) should be a focus when evaluating SUI surgery given the quality-of-life nature of this condition affecting 25-45% women worldwide (Milsom and Gyhagen 1). As part of the first step in developing a core outcome set (COS) and measures set (COMS), we aimed to systematically review RCTs evaluating SUI surgery and extract PROs and outcome measures (PROMs) used.
We searched databases including MEDLINE and Cochrane for RCTs evaluating SUI surgical treatments from inception to January 2020. Eligibility criteria included English language and female-only subjects. PROs and PROMs were extracted and grouped into a structured inventory. PROMs were assigned to domains based on predominant theme.
Of 123 eligible RCTs, 116 (94%) included PROs. Forty-four different PROMs were utilized; most frequent was Patient Global Impression of Improvement (PGI-I). Fifteen PROMs were used once. The top five PROMs have evidence of validity and are highly recommended.
There is no consensus amongst relevant stakeholders regarding PROs or PROMs used in SUI surgery research. We propose that this consensus is required to standardize measurements and reporting and promote use of validated and reliable outcome measures. This systematic review forms the first step in the development process.
网片争议突出表明需要有强有力的治疗安全性和疗效证据,特别是在治疗压力性尿失禁(SUI)的手术治疗方面。目前的试验表明,报告的结果和使用的结果测量方法存在异质性,限制了综合数据和产生强有力的研究证据的能力(Doumouchtsis 等人,5)。鉴于影响全球 25-45%女性的这种对生活质量有影响的疾病,患者报告的结局(PROs)在评估 SUI 手术时应该是重点(Milsom 和 Gyhagen,1)。作为制定核心结局集(COS)和措施集(COMS)的第一步的一部分,我们旨在系统地回顾评估 SUI 手术的 RCT,并提取使用的 PRO 和结局测量(PROM)。
我们检索了包括 MEDLINE 和 Cochrane 在内的数据库,以获取从成立到 2020 年 1 月评估 SUI 手术治疗的 RCT。纳入标准包括英语语言和仅女性受试者。提取 PRO 和 PROM 并将其分组到一个结构化清单中。根据主要主题将 PROM 分配到各个领域。
在 123 项合格的 RCT 中,有 116 项(94%)包含 PRO。使用了 44 种不同的 PROM;最常用的是患者总体印象改善(PGI-I)。有 15 种 PROM 仅使用过一次。前五种 PROM 具有有效性证据,强烈推荐使用。
在 SUI 手术研究中,利益相关者之间对于 PRO 或 PROM 没有达成共识。我们建议需要达成这种共识,以标准化测量和报告,并促进使用经过验证和可靠的结局测量。这项系统综述是制定过程的第一步。